35 reports

  • 4.2 HUMAN GROWTH HORMONE (HGH) BIOSIMILARS MARKET AND FORECAST
  • GLOBAL - HUMAN GROWTH HORMONE (HGH) BIOSIMILARS MARKET (MILLION US$), 2008 - 2015

The increasing compliance for human growth hormone drugs and massive unexplored market in the emerging economies, such as India and China are creating opportunities for the growth of the global human growth hormone market.

  • Biosimilar
  • World
  • Market Size
  • Amgen Inc.
  • Biocon Limited

Human Growth Hormones ##. ##. ##. ##. ##.

  • Biosimilar
  • Medical Biotechnology
  • United States
  • Forecast
  • Market Size

Human Growth Hormones ##. ##.

  • Biosimilar
  • Medical Biotechnology
  • World
  • Market Size

REST OF WORLD PART D: ANNEXURE ##.

  • Biosimilar
  • Europe
  • North America
  • World
  • Market Shares

##. ##. ## Biosimilar Human Insulin in China ##. ##. ## Biosimilar Human Insulin in India ##. ##. ##. ## Wockhardt and Biocon - Given up on their Desire to Target the US and Europe?

  • Biosimilar
  • Medical Biotechnology
  • World
  • Market Shares
  • Market Size

Human growth hormone ##. ##. ##.

  • Biosimilar
  • Medical Biotechnology
  • ASEAN
  • China
  • Market Size
  • 6.1 Sandoz

Amgen operates in one business segment: human therapeutics.

  • Biosimilar
  • Amgen Inc.
  • Celltrion, Inc.
  • Pfizer Inc.
  • Sandoz Inc.
  • Share of erythropoietin drugs market in Europe 2016
  • Erythropoietin drugs market in EMEA 2016-2021 ($ billions)

EMEA is the dominant market, representing ##% of global biosimilar spending. ## biosimilar products are authorized in four molecule classes: human growth hormone, EPO, G-CSF, and tumour necrosis factor (TNF)-inhibitors.

  • Biosimilar
  • World
  • Forecast
  • Amgen Inc.
  • Kyowa Hakko Kirin Co., Ltd.

Market Segmentation by Product Type ##. ## Erythropoietin (EPO) ##. ## Human Growth Hormone (HGH) ##. ## Granulocyte- Colony Stimulating Factor (G-CSF) ##. ## Monoclonal Antibody (mAb) ##. ## Insulin ##. ## Interferon (IFN) ##. ## Others ##.

  • Biosimilar
  • Medical Biotechnology
  • World
  • Market Size

Biosimilars Market By Product, By Technology, By Indication, By Manufacturing Type, By Route of Administration, by Geography - Global Market Size, Share, Development, Growth, and Demand Forecast, 2014-2024 Chapter ##.

  • Biosimilar
  • Europe
  • North America
  • World
  • Market Size

Medium Hospitals IMPACT OF BIOLOGICS IN MUSCULOSKELETAL DISORDERS BIOLOGICS INCLUDE RECOMBINANT INSULIN, HUMAN GROWTH HORMONES, ERYTHROPOIETINSTIMULATING FACTORS, AND MABS.

  • Biosimilar
  • World
  • AbbVie Inc.
  • Amgen Inc.
  • Eli Lilly & Co.
  • Business Profile

Pfizer' s rare diseases products include BeneFix and Refacto AF/ Xyntha for hemophilia, Genotropin for replacement of human growth hormone; Somavert for acromegaly; and Rapamune for prevention of organ rejection in kidney transplantation among others.

  • Biosimilar
  • Market Size
  • Allergan plc
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • HUMAN GROWTH HORMONE (HGH) BIOSIMILARS MARKETS
  • HGH BIOSIMILARS MARKET FORECASTS, ($M), 2013-2020

THE COMPANY MARKETS FOLLOW-ON VERSIONS OF THREE BIOPHARMACEUTICAL DRUGS OMNITROPE (HUMAN GROWTH HORMONE), BINOCRIT (EPOETINALFA) AND ZARZIO (G-CSF).

  • Biosimilar
  • Biocon Limited
  • Hospira, Inc.
  • Roche Group
  • Sandoz Inc.

Biosimilars and Follow-On Biologics’ Trends, R& D and Revenue Forecasts 2016-2026: Assess Prospects for MAbs, Fusion Proteins, Insulin, G-CSF, Erythropoietin, Interferons, Growth and Fertility Hormones ##.

  • Biosimilar
  • Medical Biotechnology
  • World
  • Market Shares
  • Market Size
  • Factors influencing biologics and biosimilars
  • Comparison between biosimilars and generic small molecules

The product acts by targeting the human epidermal growth factor receptor (EGFR).

  • Biosimilar
  • Biocon Limited
  • Celltrion, Inc.
  • Hospira, Inc.
  • Sandoz Inc.

Name Product Target / Mechanism of Action Tumor necrosis factor (TNF) inhibitor TNF alpha antagonist Tumor necrosis factor (TNF) alpha antagonist Vascular endothelial growth factor (VEGF) antagonist Her## inhibitor Rec human- ## ## Axxo Axxo Axxo Axxo Axxo Class of Co

  • Biosimilar
  • Genentech, Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Roche Group
  • 5.2 Biosimilars

Human growth hormones are a naturally occurring protein hormone produced by the pituitary gland.

  • Biosimilar
  • World
  • Baxter International Inc.
  • Merck & Co., Inc.
  • Novo Nordisk Group
  • BIOSIMILARS MARKET, BY PRODUCT, 2018 VS. 2023 (USD MILLION)
  • BIOSIMILARS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)

Since then, human growth hormone/ somatropin and erythropoietin have both gained high shares in the EU market.

  • Biosimilar
  • Medical Biotechnology
  • Forecast
  • Market Size
  • Sandoz Inc.
  • MARKET DYNAMICS
  • INTERVIEW TRANSCRIPTS

DRUG OVERVIEW SOMATROPIN IS A FORM OF HUMAN GROWTH HORMONE THAT IS USED IN TREATMENT OF GROWTH FAILURE IN CHILDREN AND ADULTS LACKING NATURAL GROWTH HORMONE.

  • Biosimilar
  • North America
  • United States
  • Market Size
  • Sandoz Inc.
  • Biosimilars and biologics industry

Biologics such as recombinant insulin, human growth hormone, erythropoietin, stimulating factors, and monoclonal antibodies generated revenue of more than $## billion in 2013.

  • Biosimilar
  • Medical Biotechnology
  • Chugai Pharmaceutical Co., Ltd.
  • Kissei Pharmaceutical Co., Ltd.
  • Kyowa Hakko Kirin Co., Ltd.

Therapy Area Cardiovascular Central Nervous System Dermatology Ear Nose Throat Disorders Gastrointestinal Genetic Disorders Genito Urinary System And Sex Hormones Hormonal Disorders Infectious Disease Musculoskeletal Oncology Respiratory Women' s Health Immunology No. of Deals

  • Biosimilar
  • United States
  • World
  • Deals & Alliance
  • Sandoz Inc.
  • PARTNERSHIPS
  • EQUITY OFFERING

Its products are used for long-acting human growth hormone, long-acting factor Vlla, breast/ gastric cancer ADC, ovarian cancer ADC, eyelea biosimilar and herceptin biosimilar.

  • Biosimilar
  • East Asia
  • South Korea
  • Deals & Alliance
  • Alteogen Inc
  • PIPELINE BY ALTEOGEN INC, H2 2018
  • PIPELINE BY BENITEC BIOPHARMA LTD, H2 2018

Its products are used for long-acting human growth hormone, long-acting factor Vlla, breast/ gastric cancer ADC, ovarian cancer ADC, eyelea biosimilar and herceptin biosimilar.

  • Biosimilar
  • Ophthalmology
  • United States
  • World
  • Regeneron Pharmaceuticals, Inc.

PF-## (hGH-CTP, long-acting human growth hormone) -- OPKO Health, Inc.

  • Biosimilar
  • United States
  • Company
  • Corporate Finance
  • Pfizer Inc.

PF-## (hGH-CTP, long-acting human growth hormone) -- OPKO Health, Inc.

  • Biosimilar
  • Therapy
  • United States
  • Corporate Finance
  • Pfizer Inc.

TEPROTUMUMAB (R-##) IS AN INSULIN LIKE GROWTH FACTOR ## (IGF-##) RECEPTOR ANTAGONIST.

  • Biosimilar
  • Pharmaceutical
  • United States
  • World
  • Product Initiative

Isarna' cytokine human transforming growth factor beta is used for cell proliferation, cell differentiation, immune response, and tissue modelling, among others.

  • Biosimilar
  • Medical Biotechnology
  • United States
  • Company
  • Product Initiative
  • somatropin

Human growth hormone (hGH) binds to the human growth hormone receptor (GHR).

  • Biosimilar
  • United States
  • World
  • Company Operations
  • Pfenex Inc.
  • PSORIATIC ARTHRITIS - PIPELINE BY NICHI-IKO PHARMACEUTICAL CO LTD, H2 2017

Novo Nordisk also offers biopharmaceuticals for treating hemostasis, human growth hormone products and hormone replacement therapy.

  • Autoimmune Disease
  • Biosimilar
  • Monoclonal Antibody
  • United States
  • Product Initiative

THE DRUG CANDIDATE IS AZAPEPTIDE ANALOG OF GROWTH HORMONE-RELEASING PEPTIDE-## (GHRP-##).

  • Biosimilar
  • Eye Disease
  • Monoclonal Antibody
  • Ophthalmology
  • Allergan plc